NEW YORK, Nov. 25, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Supreme Industries Inc. (“Supreme” or “the Company”) (NYSE MKT:STS) between July 22, 2016 and October 21, 2016. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Central District of California. To get more information go to:
http://www.zlk.com/pslra/supreme-industries-inc
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the class period Supreme made false and/or misleading statements and/or failed to disclose that: (1) the backlog figure from the third quarter of 2015 was a result of the timing of several large orders placed in that quarter; (2) the backlog figure for the third quarter of 2016 would not be close to the backlog figure of the third quarter of 2015; and (3) as a result, Defendants’ public statements about Supreme Industries’ business, operations and prospects were materially false and misleading at all relevant times.
If you suffered a loss in Supreme you have until January 3, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 



